← FDA Drug Approvals (Drugs@FDA)
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2021-02-18
Drug application
- FDA Application #
ANDA208111- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
- Generic name
- AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE
- Active ingredients
- AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- PADAGIS ISRAEL
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- First approval
- 2021-02-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown